IMMUNOTHERAPY IN ONCOLOGY

Serial Number 97154897
Registration 7281228
700

Registration Progress

Application Filed
Dec 3, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered
Jan 16, 2024

Trademark Image

IMMUNOTHERAPY IN ONCOLOGY

Basic Information

Serial Number
97154897
Registration Number
7281228
Filing Date
December 3, 2021
Registration Date
January 16, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 16, 2024
Registration
Registered
Classes
016

Rights Holder

The Lynx Group, LLC

16
Address
1249 South River Road, Suite 202A
Cranbury, NJ 08512

Ownership History

The Lynx Group, LLC

Original Applicant
16
Cranbury, NJ

The Lynx Group, LLC

Original Registrant
16
Cranbury, NJ

Legal Representation

Attorney
Brian L. Petrequin, Esq.

USPTO Deadlines

Next Deadline
1631 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-16)
Due Date
January 16, 2030
Grace Period Ends
July 16, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Jan 22, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 17, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 16, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 16, 2024 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Aug 2, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Aug 1, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Aug 1, 2023 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Jul 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 24, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 24, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jul 24, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jul 22, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Apr 21, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Apr 21, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 24, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 24, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 24, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 25, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 25, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 25, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 26, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 26, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 26, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 19, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 7, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Printed publications, namely, peer-reviewed medical magazines, journals, newsletters, feature reports, monographs, and printed supplements to the foregoing in the fields of immunology, hematology, oncology and cancer
First Use Anywhere: 20110600
First Use in Commerce: Jun 1, 2023

Classification

International Classes
016